NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is offering renewal awards for SBIR Phase II grants to support pre-clinical research. The goal of this funding opportunity is to facilitate the transition of previously funded SBIR and STTR Phase II projects to the commercialization stage by promoting partnerships between NINDS SBIR or STTR awardees and third-party investors and/or strategic partners. Key points to consider include: • Eligibility is limited to small businesses. • The opportunity is for pre-clinical research and does not allow clinical trials. • Applicants are strongly encouraged to secure independent third-party funding throughout the project period. • The funding instrument for this opportunity is a grant. • The application deadline is April 5, 2027.